These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34896517)

  • 41. The risk factors for complications and survival outcomes of Klebsiella pneumoniae Bacteraemia in Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia.
    Ang SH; Petrick P; Shamsul AS; Ramliza R; Kori N; Lau CL
    Med J Malaysia; 2022 Jul; 77(4):440-445. PubMed ID: 35902933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
    Shurland S; Zhan M; Bradham DD; Roghmann MC
    Infect Control Hosp Epidemiol; 2007 Mar; 28(3):273-9. PubMed ID: 17326017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association Between Staphylococcus aureus Bacteremia and Hospital Mortality in Hemodialysis Patients With Bloodstream Infection: A Multicenter Cohort From Japanese Tertiary Care Centers.
    Imaizumi T; Hasegawa T; Nomura A; Sasaki S; Nishiwaki H; Ozeki T; Shimizu H; Minatoguchi S; Yamakawa T; Yazawa M; Uchida D; Kawarazaki H; Miyamoto M; Suzuki T; Koitabashi K; Furusho M; Fujita Y
    Ther Apher Dial; 2017 Aug; 21(4):354-360. PubMed ID: 28498647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
    Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
    Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Host-Pathogen-Treatment Triad: Host Factors Matter Most in Methicillin-Resistant Staphylococcus aureus Bacteremia Outcomes.
    Guillamet MCV; Vazquez R; Deaton B; Shroba J; Vazquez L; Mercier RC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia.
    Lesse AJ; Mylotte JM
    Am J Infect Control; 2006 Dec; 34(10):642-50. PubMed ID: 17161739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.
    Chong YP; Moon SM; Bang KM; Park HJ; Park SY; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1150-6. PubMed ID: 23254436
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Jaganath D; Jorakate P; Makprasert S; Sangwichian O; Akarachotpong T; Thamthitiwat S; Khemla S; DeFries T; Baggett HC; Whistler T; Gregory CJ; Rhodes J
    Am J Trop Med Hyg; 2018 Jul; 99(1):155-163. PubMed ID: 29761760
    [No Abstract]   [Full Text] [Related]  

  • 49. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB).
    Sohail MR; Palraj BR; Khalid S; Uslan DZ; Al-Saffar F; Friedman PA; Hayes DL; Lohse CM; Wilson WR; Steckelberg JM; Baddour LM
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):137-44. PubMed ID: 25504648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis.
    Joo EJ; Park DA; Kang CI; Chung DR; Song JH; Lee SM; Peck KR
    Korean J Intern Med; 2019 Nov; 34(6):1347-1362. PubMed ID: 29347812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A major reduction in hospital-onset Staphylococcus aureus bacteremia in Australia-12 years of progress: an observational study.
    Mitchell BG; Collignon PJ; McCann R; Wilkinson IJ; Wells A
    Clin Infect Dis; 2014 Oct; 59(7):969-75. PubMed ID: 24973314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxic Shock Syndrome Toxin 1-Producing Methicillin-Resistant Staphylococcus aureus of Clonal Complex 5, the New York/Japan Epidemic Clone, Causing a High Early-Mortality Rate in Patients with Bloodstream Infections.
    Kim D; Hong JS; Yoon EJ; Lee H; Kim YA; Shin KS; Shin JH; Uh Y; Shin JH; Park YS; Jeong SH
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction of 30-day death rates from Staphylococcus aureus bacteremia by mandatory infectious diseases consultation: Comparative study interventions with and without an infectious disease specialist.
    Hadano Y; Kakuma T; Matsumoto T; Ishibashi K; Isoda M; Yasunaga H
    Int J Infect Dis; 2021 Feb; 103():308-315. PubMed ID: 33278619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study.
    Wang JT; Hsu LY; Lauderdale TL; Fan WC; Wang FD
    PLoS One; 2015; 10(12):e0144710. PubMed ID: 26690351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.
    Roghmann MC
    Arch Intern Med; 2000 Apr; 160(7):1001-4. PubMed ID: 10761966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
    Rasmussen JB; Knudsen JD; Arpi M; Schønheyder HC; Benfield T; Ostergaard C
    J Antimicrob Chemother; 2014 Feb; 69(2):506-14. PubMed ID: 24078468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2018.
    Coombs GW; Daley DA; Mowlaboccus S; Lee YT; Pang S;
    Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.
    Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort.
    Mylotte JM; Tayara A
    Clin Infect Dis; 2000 Nov; 31(5):1170-4. PubMed ID: 11073748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.